Well if you have been paying attention old mate you would have a better understanding…….All we need to be concerned about is a green light for a phase 3 trial, plenty of big Pharmas throughout the world who would love to break into the HIV space if it will give them a return on their investment, or maybe the big Pharmas in the HIV space don’t want that Lol or maybe the big Pharma companies in the HIV space would like a new drug for themselves. Anyhow outstanding results will generate a lot of interest.
COVID19 - competitive landscape, page-191
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 968248 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 900263 | 3 |
View Market Depth
| Last trade - 16.12pm 08/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable